MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.surg.2023.02.008

Медицинская библиотека · Surgery · 2023

Revival of associating liver partition and portal vein ligation for staged hepatectomy for perihilar cholangiocarcinoma: An international multicenter study with promising outcomes.

Balci Deniz, Nadalin Silvio, Mehrabi Arianeb, Alikhanov Ruslan, Fernandes Eduardo S M, Di Benedetto Fabrizio, Hernandez-Alejandro Roberto, Björnsson Bergthor, Efanov Mikhail, Capobianco Ivan, Clavien Pierre-Alain, Kirimker Elvan Onur, Petrowsky Henrik

Многоцентровое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Associating liver partition and portal vein ligation for staged hepatectomy for perihilar cholangiocarcinoma has been considered to be contraindicated due to the initial poor results. Given the recent reports of improved outcomes, we aimed to collect the recent experiences of different centers performing associating liver partition and portal vein ligation for staged hepatectomy for perihilar cholangiocarcinoma to analyze factors related to improved outcomes.

METHODS

This proof-of-concept study collected contemporary cases of associating liver partition and portal vein ligation for staged hepatectomy for perihilar cholangiocarcinoma and analyzed for morbidity, short and long-term survival, and factors associated with outcomes.

RESULTS

In total, 39 patients from 8 centers underwent associating liver partition and portal vein ligation for staged hepatectomy for perihilar cholangiocarcinoma from 2010 to 2020. The median preoperative future liver remnant volume was 323 mL (155-460 mL). The median future liver remnant increase was 58.7% (8.9% -264.5%) with a median interstage interval of 13 days (6-60 days). Post-stage 1 and post-stage 2 biliary leaks occurred in 2 (7.7%) and 4 (15%) patients. Six patients (23%) after stage 1 and 6 (23%) after stage 2 experienced grade 3 or higher complications. Two patients (7.7%) died within 90 days after stage 2. The 1-, 3-, and 5-year survival was 92%, 69%, and 55%, respectively. A subgroup analysis revealed poor survival for patients undergoing additional vascular resection and lymph node positivity. Lymph node-negative patients showed excellent survival demonstrated by 1-, 3-, and 5-year survival of 86%, 86%, and 86%.

CONCLUSION

This study highlights that the critical attitude toward associating liver partition and portal vein ligation for staged hepatectomy for perihilar cholangiocarcinoma needs to be revised. In selected patients with perihilar cholangiocarcinoma, associating liver partition and portal vein ligation for staged hepatectomy can achieve favorable survival that compares to the outcome of established surgical treatment strategies reported in benchmark studies for perihilar cholangiocarcinoma including 1-stage hepatectomy and liver transplantation.

Для цитирования: Balci Deniz, Nadalin Silvio, Mehrabi Arianeb, Alikhanov Ruslan, Fernandes Eduardo S M, Di Benedetto Fabrizio, Hernandez-Alejandro Roberto, Björnsson Bergthor, Efanov Mikhail, Capobianco Ivan, Clavien Pierre-Alain, Kirimker Elvan Onur, Petrowsky Henrik. Revival of associating liver partition and portal vein ligation for staged hepatectomy for perihilar cholangiocarcinoma: An international multicenter study with promising outcomes.. Surgery. 2023. DOI: 10.1016/j.surg.2023.02.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.